These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 8231171

  • 21. Irreversible binding of the fluorescent beta-adrenoceptor probes alprenolol-NBD and pindolol-NBD to specific and non-specific binding sites.
    Rademaker B, Kramer K, Bast A, Timmerman H.
    Res Commun Chem Pathol Pharmacol; 1988 May; 60(2):147-59. PubMed ID: 2839876
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Turnover of beta 1- and beta 2-adrenergic receptors after down-regulation or irreversible blockade.
    Neve KA, Molinoff PB.
    Mol Pharmacol; 1986 Aug; 30(2):104-11. PubMed ID: 3016496
    [Abstract] [Full Text] [Related]

  • 24. Differential distribution of beta-1 and beta-2 adrenergic receptors in cat and guinea-pig heart.
    Hedberg A, Minneman KP, Molinoff PB.
    J Pharmacol Exp Ther; 1980 Mar; 212(3):503-8. PubMed ID: 6244386
    [Abstract] [Full Text] [Related]

  • 25. Characterization of beta-adrenergic receptors throughout the replicative life span of IMR-90 cells.
    Scarpace PJ.
    J Cell Physiol; 1987 Jan; 130(1):163-7. PubMed ID: 3027107
    [Abstract] [Full Text] [Related]

  • 26. Genetic influences on agonist binding to cardiac beta-receptors.
    Christ GJ, Dunlap CE, Blizard DA.
    Biochem Pharmacol; 1988 Apr 01; 37(7):1281-6. PubMed ID: 2895654
    [Abstract] [Full Text] [Related]

  • 27. Axonal transport of beta-adrenergic receptors. Antero- and retrogradely transported receptors differ in agonist affinity and nucleotide sensitivity.
    Zarbin MA, Palacios JM, Wamsley JK, Kuhar MJ.
    Mol Pharmacol; 1983 Sep 01; 24(2):341-8. PubMed ID: 6193407
    [Abstract] [Full Text] [Related]

  • 28. Modulation of myocardial alpha 1- but not beta-adrenoceptors after 90-day tail-suspension.
    Chen J, Zhang LF, Han C, Yu GS, Ma J.
    J Gravit Physiol; 1996 Apr 01; 3(1):57-62. PubMed ID: 11539308
    [Abstract] [Full Text] [Related]

  • 29. Desensitization of beta-adrenergic receptors by pheochromocytoma.
    Tsujimoto G, Manger WM, Hoffman BB.
    Endocrinology; 1984 Apr 01; 114(4):1272-8. PubMed ID: 6323140
    [Abstract] [Full Text] [Related]

  • 30. Evidence for two specific affinity states of 3H-antagonist binding to cardiac beta-adrenergic receptors and influence of Gpp(NH)p.
    Lang PH, Lemmer B.
    J Cyclic Nucleotide Protein Phosphor Res; 1985 Apr 01; 10(4):341-60. PubMed ID: 2993385
    [Abstract] [Full Text] [Related]

  • 31. Quantitative analysis of the selectivity of radioligands for subtypes of beta adrenergic receptors.
    Neve KA, McGonigle P, Molinoff PB.
    J Pharmacol Exp Ther; 1986 Jul 01; 238(1):46-53. PubMed ID: 3014123
    [Abstract] [Full Text] [Related]

  • 32. (-)-[125I]-iodopindolol, a new highly selective radioiodinated beta-adrenergic receptor antagonist: measurement of beta-receptors on intact rat astrocytoma cells.
    Barovsky K, Brooker G.
    J Cyclic Nucleotide Res; 1980 Jul 01; 6(4):297-307. PubMed ID: 6110683
    [Abstract] [Full Text] [Related]

  • 33. A new approach to determine rates of receptor appearance and disappearance in vivo. Application to agonist-mediated down-regulation of rat renal cortical beta 1- and beta 2-adrenergic receptors.
    Snavely MD, Ziegler MG, Insel PA.
    Mol Pharmacol; 1985 Jan 01; 27(1):19-26. PubMed ID: 2981399
    [Abstract] [Full Text] [Related]

  • 34. Ligand binding to the beta-adrenergic receptor involves its rhodopsin-like core.
    Dixon RA, Sigal IS, Rands E, Register RB, Candelore MR, Blake AD, Strader CD.
    Nature; 1985 Jan 01; 326(6108):73-7. PubMed ID: 2881211
    [Abstract] [Full Text] [Related]

  • 35. Comparison of agonist-induced changes in beta- and alpha 1-adrenergic receptors of DDT1 MF-2 cells.
    Toews ML.
    Mol Pharmacol; 1987 Jan 01; 31(1):58-68. PubMed ID: 2880284
    [Abstract] [Full Text] [Related]

  • 36. Differences in beta adrenergic receptor agonist affinity between cardiac myocytes and coronary arterioles in canine heart.
    Cooke L, Muntz KH.
    J Pharmacol Exp Ther; 1994 Apr 01; 269(1):351-7. PubMed ID: 7909560
    [Abstract] [Full Text] [Related]

  • 37. Electron microscopic localization of the beta-adrenergic receptor using a ferritin-alprenolol probe.
    Muntz KH, Calianos TA, Buja LM, Willerson JT, Bernatowicz M, Homcy CJ, Graham RM.
    Mol Pharmacol; 1988 Oct 01; 34(4):444-51. PubMed ID: 2845247
    [Abstract] [Full Text] [Related]

  • 38. Species comparison of adenosine and beta-adrenoceptors in mammalian atrial and ventricular myocardium.
    Musser B, Morgan ME, Leid M, Murray TF, Linden J, Vestal RE.
    Eur J Pharmacol; 1993 Jul 15; 246(2):105-11. PubMed ID: 8397091
    [Abstract] [Full Text] [Related]

  • 39. Interactions of agonists and antagonists with beta-adrenergic receptors on intact L6 muscle cells.
    Pittman RN, Molinoff PB.
    J Cyclic Nucleotide Res; 1980 Jul 15; 6(6):421-35. PubMed ID: 6260844
    [Abstract] [Full Text] [Related]

  • 40. [Alterations in number of rabbit myocardial beta-adrenergic receptors in endotoxic shock: down regulation in hyperdynamic sepsis model and effects of cytokines administration].
    Yahagi M, Honda T, Mizumachi K, Tezuka S, Okada K.
    Kokyu To Junkan; 1991 Dec 15; 39(12):1209-14. PubMed ID: 1664539
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.